miRNAs in treatment-resistant depression: a systematic review

被引:3
作者
Cai, Lun [1 ]
Xu, Jingwen [1 ]
Liu, Jie [1 ]
Luo, Huazheng [1 ]
Yang, Rongrong [1 ]
Gui, Xiongbin [2 ]
Wei, Liping [2 ]
机构
[1] Guangxi Univ Chinese Med, Guangxi Univ Chinese Med, Dept Neurol, Affiliated Hosp 1, Nanning 530023, Peoples R China
[2] Guangxi Univ Chinese Med, Guangxi Univ Chinese Med, Dept Surg, Affiliated Hosp 1, 89-9 Dongge Rd, Nanning 530000, Guangxi, Peoples R China
基金
中国国家自然科学基金;
关键词
Treatment-resistant depression; miRNAs; Systematic review; SYNAPTIC PLASTICITY; NEUROTROPHIC FACTOR; EMERGING ROLE; MICRORNAS; BRAIN; BDNF; INFLAMMATION; DEFINITION; DIAGNOSIS; DISORDER;
D O I
10.1007/s11033-024-09554-x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
BackgroundTreatment-resistant depression (TRD) is a condition in a subset of depressed patients characterized by resistance to antidepressant medications. The global prevalence of TRD has been steadily increasing, yet significant advancements in its diagnosis and treatment remain elusive despite extensive research efforts. The precise underlying pathogenic mechanisms are still not fully understood. Epigenetic mechanisms play a vital role in a wide range of diseases. In recent years, investigators have increasingly focused on the regulatory roles of miRNAs in the onset and progression of TRD. miRNAs are a class of noncoding RNA molecules that regulate the translation and degradation of their target mRNAs via interaction, making the exploration of their functions in TRD essential for elucidating their pathogenic mechanisms.Methods and resultsA systematic search was conducted in four databases, namely PubMed, Web of Science, Cochrane Library, and Embase, focusing on studies related to treatment-resistant depression and miRNAs. The search was performed using terms individually or in combination, such as "treatment-resistant depression," "medication-resistant depression," and "miRNAs." The selected articles were reviewed and collated, covering the time period from the inception of each database to the end of February 2024. We found that miRNAs play a crucial role in the pathophysiology of TRD through three main aspects: 1) involvement in miRNA-mediated inflammatory responses (including miR-155, miR-345-5p, miR-146a, and miR-146a-5p); 2) influence on 5-HT transport processes (including miR-674,miR-708, and miR-133a); and 3) regulation of synaptic plasticity (including has-miR-335-5p,has-miR- 1292-3p, let-7b, and let-7c). Investigating the differential expression and interactions of these miRNAs could contribute to a deeper understanding of the molecular mechanisms underlying TRD.ConclusionsmiRNAs might play a pivotal role in the pathogenesis of TRD. Gaining a deeper understanding of the roles and interrelations of miRNAs in TRD will contribute to elucidating disease pathogenesis and potentially provide avenues for the development of novel diagnostic and therapeutic strategies.
引用
收藏
页数:12
相关论文
共 68 条
[1]  
Abbafati C, 2020, LANCET, V396, P1204
[2]   Treatment resistant depression: A multi-scale, systems biology approach [J].
Akil, Huda ;
Gordon, Joshua ;
Hen, Rene ;
Javitch, Jonathan ;
Mayberg, Helen ;
McEwen, Bruce ;
Meaney, Michael J. ;
Nestler, Eric J. .
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 2018, 84 :272-288
[3]   Modifying 5-HT1A receptor gene expression as a new target for antidepressant therapy [J].
Albert, Paul R. ;
Le Francois, Brice .
FRONTIERS IN NEUROSCIENCE, 2010, 4
[4]   Interaction between 5-HT1A and BDNF genotypes increases the risk of treatment-resistant depression [J].
Anttila, S. ;
Huuhka, K. ;
Huuhka, M. ;
Rontu, R. ;
Hurme, M. ;
Leinonen, E. ;
Lehtima, T. .
JOURNAL OF NEURAL TRANSMISSION, 2007, 114 (08) :1065-1068
[5]   Responder and nonresponder patients exhibit different peripheral transcriptional signatures during major depressive episode [J].
Belzeaux, R. ;
Bergon, A. ;
Jeanjean, V. ;
Loriod, B. ;
Formisano-Treziny, C. ;
Verrier, L. ;
Loundou, A. ;
Baumstarck-Barrau, K. ;
Boyer, L. ;
Gall, V. ;
Gabert, J. ;
Nguyen, C. ;
Azorin, J-M ;
Naudin, J. ;
Ibrahim, E. C. .
TRANSLATIONAL PSYCHIATRY, 2012, 2 :e185-e185
[6]   Definition, assessment, and staging of treatment-resistant refractory major depression: A review of current concepts and methods [J].
Berlim, Marcelo T. ;
Turecki, Gustavo .
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 2007, 52 (01) :46-54
[7]   Serotonin transporter gene polymorphisms and treatment-resistant depression [J].
Bonvicini, Cristian ;
Minelli, Alessandra ;
Scassellati, Catia ;
Bortolomasi, Marco ;
Segala, Matilde ;
Sartori, Riccardo ;
Giacopuzzi, Mario ;
Gennarelli, Massimo .
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2010, 34 (06) :934-939
[8]   Novel drug developmental strategies for treatment-resistant depression [J].
Borbely, Eva ;
Simon, Maria ;
Fuchs, Eberhard ;
Wiborg, Ove ;
Czeh, Boldizsar ;
Helyes, Zsuzsanna .
BRITISH JOURNAL OF PHARMACOLOGY, 2022, 179 (06) :1146-1186
[9]   Neuroinflammation and Depression: Microglia Activation, Extracellular Microvesicles and microRNA Dysregulation [J].
Brites, Dora ;
Fernandes, Adelaide .
FRONTIERS IN CELLULAR NEUROSCIENCE, 2015, 9 :1-20
[10]   Depression and Alzheimer's disease: Neurobiological links and common pharmacological targets [J].
Caraci, Filippo ;
Copani, Agata ;
Nicoletti, Ferdinando ;
Drago, Filippo .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2010, 626 (01) :64-71